Long-term Hemoglobin Control
Long-Term Hemoglobin Control is a clinical management framework in anemia management for hemodialysis patients that specifically enables the sustained regulation of hemoglobin levels within a target therapeutic range over extended periods through systematic monitoring, individualized treatment adjustments, and predictive interventions.
207
Publications
14.2K
Citations
1.2K
Authors
576
Institutions
Publications per year
2017–2026
36
207
Brian Leyland‐Jones, Marek Pawlicki, Tadeusz Pieńkowski et al. · Journal of Clinical Oncology · 2005 · 665 citations · Full text
Medicine, Oncology, Pharmacology +15
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors
Gèrard Socié, Jean‐Yves Mary, Aimery de Gramont et al. · The Lancet · 1996 · 516 citations
1–5 of 207
1.2K
13
h-index
9
h-index
6
h-index
6
h-index
Arbor Research Collaborative for Health, United States
6 publications · 422 citations
6
h-index
1–5 of 1.2K
576
Amgen (United States)
Thousand Oaks, United States
13 h-index
34 publications
1.2K citations
SHOWA Medical University
Tokyo, Japan
10 h-index
10 publications
484 citations
Alessandro Manzoni Hospital
Lecco, Italy
8 h-index
14 publications
3.5K citations
Roche (Switzerland)
Basel, Switzerland
8 h-index
26 publications
6.9K citations
The University of Tokyo
Tokyo, Japan
7 h-index
8 publications
306 citations
Memorial University of Newfoundland
St. John's, Canada
7 h-index
25 publications
8.4K citations
Arbor Research Collaborative for Health
Ann Arbor, United States
7 h-index
21 publications
1.6K citations

University of Toronto
Toronto, Canada
6 h-index
22 publications
680 citations
1–8 of 576
NDT · 29 publications · 1.4K citations
22
h-index
Repository · 13 publications · 260 citations
11
h-index
AJKD · 9 publications · 1.8K citations
9
h-index
8 publications · 1.3K citations
8
h-index
CJASN · 8 publications · 714 citations
8
h-index
1–5